Literature DB >> 17185520

Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.

Hiroaki Kajiyama1, Kiyosumi Shibata, Mikio Terauchi, Kazuhiko Ino, Akihiro Nawa, Fumitaka Kikkawa.   

Abstract

Dipeptidyl peptidase IV (DPPIV) is a multifunctional cell surface aminopeptidase with ubiquitous expression and it has a variety of functional properties in the development of human malignancies. In the present study, we showed the possible correlation between DPPIV/CD26 expression and less migratory potential with decreased MMP-2 expression in ovarian carcinoma cells. Moreover, induction of DPPIV/CD26 resulted in reduced expressions of MMP-2 and mesenchymal markers such as vimentin and SMA, with a less invasive potential and an epithelial morphologic change. This evidence implies that DPPIV/CD26 may play a crucial role in the antimetastatic potential in ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185520     DOI: 10.1196/annals.1377.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.

Authors:  Ayper Kacar; Ata Türker Arikok; Tuba Dilay Kokenek Unal; Evrim Onder; Sema Hucumenoglu; Murat Alper
Journal:  Pathol Oncol Res       Date:  2011-06-15       Impact factor: 3.201

2.  Chronic activation profile of circulating CD8+ T cells in Sézary syndrome.

Authors:  Marina Passos Torrealba; Kelly Cristina Manfrere; Denis R Miyashiro; Josenilson F Lima; Luana de M Oliveira; Nátalli Z Pereira; Jade Cury-Martins; Juliana Pereira; Alberto J S Duarte; Maria N Sato; José A Sanches
Journal:  Oncotarget       Date:  2017-12-16

3.  Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion.

Authors:  Ekta Manocha; Antonella Bugatti; Mirella Belleri; Alberto Zani; Stefania Marsico; Francesca Caccuri; Marco Presta; Arnaldo Caruso
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

Review 4.  Targeting purine metabolism in ovarian cancer.

Authors:  Jingchun Liu; Shasha Hong; Jiang Yang; Xiaoyi Zhang; Ying Wang; Haoyu Wang; Jiaxin Peng; Li Hong
Journal:  J Ovarian Res       Date:  2022-08-13       Impact factor: 5.506

5.  Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.

Authors:  W T Arscott; A E LaBauve; V May; U V Wesley
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

6.  Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.

Authors:  Aline Beckenkamp; Júlia Biz Willig; Danielle Bertodo Santana; Jéssica Nascimento; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Alessandra Nejar Bruno; Diogo André Pilger; Márcia Rosângela Wink; Andréia Buffon
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

7.  DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.

Authors:  Peir-In Liang; Bi-Wen Yeh; Wei-Ming Li; Ti-Chun Chan; I-Wei Chang; Chun-Nung Huang; Ching-Chia Li; Hung-Lung Ke; Hsin-Chih Yeh; Wen-Jeng Wu; Chien-Feng Li
Journal:  Oncotarget       Date:  2017-01-10

8.  Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Authors:  Laura R Moffitt; Maree Bilandzic; Amy L Wilson; Yiqian Chen; Mark D Gorrell; Martin K Oehler; Magdalena Plebanski; Andrew N Stephens
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.